Edition:
United Kingdom

Lupin Ltd (LUPN.NS)

LUPN.NS on National Stock Exchange of India

747.35INR
19 Jul 2019
Change (% chg)

Rs-8.80 (-1.16%)
Prev Close
Rs756.15
Open
Rs758.00
Day's High
Rs763.00
Day's Low
Rs742.15
Volume
796,473
Avg. Vol
1,866,971
52-wk High
Rs986.10
52-wk Low
Rs697.20

Latest Key Developments (Source: Significant Developments)

Lupin Launches Imatinib Mesylate Tablets
Tuesday, 9 Jul 2019 

July 9 (Reuters) - Lupin Ltd ::"LUPIN LAUNCHES IMATINIB MESYLATE TABLETS"..  Full Article

Lupin Gets U.S. FDA Approval For Cinacalcet Tablets
Wednesday, 3 Jul 2019 

July 3 (Reuters) - Lupin Ltd ::GETS U.S. FDA APPROVAL FOR CINACALCET TABLETS.  Full Article

Lupin Gets Tentative U.S. FDA Nod For Fosaprepitant For Injection
Tuesday, 7 May 2019 

May 7 (Reuters) - Lupin Ltd ::LUPIN RECEIVES TENTATIVE U.S. FDA APPROVAL FOR FOSAPREPITANT FOR INJECTION.  Full Article

Lupin Ltd Says U.S. FDA Classifies Inspection Of Pithampur Unit-2 As OAI
Tuesday, 23 Apr 2019 

April 23 (Reuters) - Lupin Ltd ::U.S. FDA CLASSIFIES INSPECTION OF LUPIN''S PITHAMPUR (INDORE) UNIT-2 FACILITY AS OAI.U.S. FDA STATES THAT FACILITY MAY BE SUBJECT TO REGULATORY OR ADMINISTRATIVE ACTION.U.S. FDA SAYS THAT IT MAY WITHHOLD APPROVAL OF ANY PENDING APPLICATIONS OR SUPPLEMENTS IN WHICH THIS FACILITY IS LISTED.DOES NOT BELIEVE THAT THIS CLASSIFICATION WILL IMPACT EXISTING REVENUES FROM OPERATIONS OF THIS FACILITY.CO IS IN PROCESS OF SENDING FURTHER UPDATES OF ITS CORRECTIVE ACTIONS TO THE U.S. FDA.  Full Article

Lupin Gets FDA Approval For Fluoxetine Tablets USP
Tuesday, 16 Apr 2019 

April 16 (Reuters) - Lupin Ltd ::RECEIVES FDA APPROVAL FOR FLUOXETINE TABLETS USP.  Full Article

Lupin Ltd Says Lupin Bioresearch Centre Completes Fifth Successful U.S. FDA Inspection
Wednesday, 3 Apr 2019 

April 3 (Reuters) - Lupin Ltd ::LUPIN BIORESEARCH CENTRE COMPLETES FIFTH SUCCESSFUL U.S. FDA INSPECTION.SUCCESSFUL COMPLETION OF U.S FDA INSPECTION AT ITS LUPIN BIORESEARCH CENTRE (LBC) WITHOUT ANY OBSERVATIONS.  Full Article

Lupin Says Pithampur Unit-3 Gets EIR From U.S. FDA
Tuesday, 2 Apr 2019 

April 2 (Reuters) - Lupin Ltd ::PITHAMPUR UNIT-3 GETS EIR FROM U.S. FDA.SAYS INSPECTION WAS CONDUCTED BETWEEN OCTOBER 8, 2018 TO OCTOBER 18, 2018.LUPIN - PITHAMPUR UNIT-3 IS INVOLVED IN MANUFACTURE OF METERED DOSE INHALERS, DRY POWDER INHALERS AND TOPICAL FORMULATIONS FOR REGULATED MARKETS.  Full Article

Lupin Says Recall Of Testosterone Topical Solution Was Classified As Class III Recall By USFDA
Tuesday, 2 Apr 2019 

April 2 (Reuters) - Lupin Ltd ::RECALL OF 3,200 BOTTLES OF TESTOSTERONE TOPICAL SOLUTION WAS CLASSIFIED AS CLASS III RECALL BY USFDA.  Full Article

Lupin Gets US FDA Approval For Sildenafil Tablets
Monday, 25 Mar 2019 

March 25 (Reuters) - Lupin Ltd ::GETS US FDA APPROVAL FOR SILDENAFIL TABLETS USP.  Full Article

Lupin Gets USFDA Approval For Atorvastatin Calcium Tablets Usp
Thursday, 7 Mar 2019 

March 7 (Reuters) - Lupin Ltd ::SAYS LUPIN RECEIVES FDA APPROVAL FOR ATORVASTATIN CALCIUM TABLETS USP.SAYS DRUG INDICATED TO LOWER CHOLESTEROL IN BLOOD FOR ADULTS AND CHILDREN OVER 10 YEARS OF AGE.  Full Article

Indian shares edge higher; Reliance Industries top boost

* Underlying market trend positive, but see some near term weakness - analyst